These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32264801)

  • 81. Buprenorphine Supply, Access, and Quality: Where We Have Come and the Path Forward.
    Breen CT; Fiellin DA
    J Law Med Ethics; 2018 Jun; 46(2):272-278. PubMed ID: 30147002
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Buprenorphine Treatment Divide by Race/Ethnicity and Payment.
    Lagisetty PA; Ross R; Bohnert A; Clay M; Maust DT
    JAMA Psychiatry; 2019 Sep; 76(9):979-981. PubMed ID: 31066881
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Association Between Receipt of Antidepressants and Retention in Buprenorphine Treatment for Opioid Use Disorder: A Population-Based Retrospective Cohort Study.
    Zhang K; Jones CM; Compton WM; Guy GP; Evans ME; Volkow ND
    J Clin Psychiatry; 2022 Apr; 83(3):. PubMed ID: 35485928
    [No Abstract]   [Full Text] [Related]  

  • 84. Availability of Buprenorphine Treatment in the 10 States With the Highest Drug Overdose Death Rates in the United States.
    Flavin L; Malowney M; Patel NA; Alpert MD; Cheng E; Noy G; Samuelson S; Sreshta N; Boyd JW
    J Psychiatr Pract; 2020 Jan; 26(1):17-22. PubMed ID: 31913966
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Telehealth Utilization Is Associated with Lower Risk of Discontinuation of Buprenorphine: a Retrospective Cohort Study of US Veterans.
    Vakkalanka JP; Lund BC; Ward MM; Arndt S; Field RW; Charlton M; Carnahan RM
    J Gen Intern Med; 2022 May; 37(7):1610-1618. PubMed ID: 34159547
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Buprenorphine treatment retention and comorbidities among patients with opioid use disorder in a primary care setting.
    Sweeney MM; Prichett L; Fingerhood MI; Antoine D; Umbricht A; Dunn KE; Buresh ME
    Am J Addict; 2022 May; 31(3):256-260. PubMed ID: 35385169
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder.
    Ronquest NA; Willson TM; Montejano LB; Nadipelli VR; Wollschlaeger BA
    Subst Abuse Rehabil; 2018; 9():59-78. PubMed ID: 30310349
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Leaving buprenorphine treatment: patients' reasons for cessation of care.
    Gryczynski J; Mitchell SG; Jaffe JH; O'Grady KE; Olsen YK; Schwartz RP
    J Subst Abuse Treat; 2014 Mar; 46(3):356-61. PubMed ID: 24238714
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Factors Associated with Long-Term Retention in Buprenorphine-Based Addiction Treatment Programs: a Systematic Review.
    Kennedy AJ; Wessel CB; Levine R; Downer K; Raymond M; Osakue D; Hassan I; Merlin JS; Liebschutz JM
    J Gen Intern Med; 2022 Feb; 37(2):332-340. PubMed ID: 33469778
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A machine learning based two-stage clinical decision support system for predicting patients' discontinuation from opioid use disorder treatment: retrospective observational study.
    Hasan MM; Young GJ; Shi J; Mohite P; Young LD; Weiner SG; Noor-E-Alam M
    BMC Med Inform Decis Mak; 2021 Nov; 21(1):331. PubMed ID: 34836524
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A mixed methods study of provider factors in buprenorphine treatment retention.
    Gertner AK; Clare HM; Powell BJ; Gilbert AR; Jones HE; Silberman P; Shea CM; Domino ME
    Int J Drug Policy; 2022 Jul; 105():103715. PubMed ID: 35533634
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Poly-substance use and antisocial personality traits at admission predict cumulative retention in a buprenorphine programme with mandatory work and high compliance profile.
    Öhlin L; Hesse M; Fridell M; Tätting P
    BMC Psychiatry; 2011 May; 11():81. PubMed ID: 21569440
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Inquiries about and initiation of buprenorphine treatment in an inner-city clinic.
    Cunningham CO; Giovanniello A; Sacajiu G; Li X; Brisbane M; Sohler NL
    Subst Abus; 2009; 30(3):261-2. PubMed ID: 19591064
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Factors Associated With Initial Treatment Choice, Engagement, and Discontinuation for Patients With Opioid Use Disorder.
    Mutter R; Spencer D; McPheeters J
    Psychiatr Serv; 2022 Jun; 73(6):604-612. PubMed ID: 34666510
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Retention rates with monthly depot buprenorphine in general practice in Melbourne, Australia.
    Andrada E; Rodriguez M; Bandalan JH; Dangelo-Kemp D; Johnston L; Wilson H
    Aust J Gen Pract; 2022 Jun; 51(6):447-451. PubMed ID: 35637592
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Initiation of Medications for Opioid Use Disorder Shortly Before Release From Prison to Promote Treatment Retention: Strong Evidence but Compromised Policy.
    Curtis M; Larney S; Higgs P; Cossar RD; Winter RJ; Stewart AC; Stoové M
    J Addict Med; 2021 Nov-Dec 01; 15(6):525-526. PubMed ID: 33298751
    [No Abstract]   [Full Text] [Related]  

  • 97. Commentary on Fishman et al. : Youth and family-centered care for young adults with opioid use disorder.
    Bagley SM; Hadland SE
    Addiction; 2021 Mar; 116(3):558-559. PubMed ID: 33269477
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Preoperative Opioid Use Is Associated With Persistent Use, Readmission and Postoperative Complications After Arthroscopic Knee Surgery.
    Ridenour R; Kowalski C; Yadavalli A; Ba D; Liu G; Leslie D; Bible J; Aynardi M; Garner M; Dhawan A
    Arthroscopy; 2021 May; 37(5):1567-1572. PubMed ID: 33340677
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Opioid Use, Perioperative Risks, and Associated Postoperative Complications in Foot and Ankle Surgery.
    Ridenour R; Kowalski C; Ba D; Liu G; Bible J; Garner M; Leslie D; Aynardi M; Dhawan A
    Foot Ankle Spec; 2022 Dec; 15(6):528-535. PubMed ID: 33307812
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.